Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William J Gradishar

Showing results (151-160 of 195) with videos related to

Pageof 20
Sort By:
The Journal of Clinical Investigation|March 26, 2024
Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancersYueming Zhu, Anupam Banerjee, Ping Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast CancerCristina Saura, Judit Matito, Mafalda Oliveira, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 4, 2006
HER2 testing in breast cancer: NCCN Task Force report and recommendationsRobert W Carlson, Susan J Moench, M Elizabeth H Hammond, et al.
JCO Oncology Practice|August 10, 2021
Evaluation of the Novel 4R Oncology Care Planning Model in Breast Cancer: Impact on Patient Self-Management and Care Delivery in Safety-Net and Non-Safety-Net CentersJulia R Trosman, Christine B Weldon, Bruce D Rapkin, et al.
Nature Communications|April 14, 2025
MGAT1-Guided complex N-Glycans on CD73 regulate immune evasion in triple-negative breast cancerJunlong Jack Chi, Ping Xie, Mary Hongying Cheng, et al.
Breast Cancer Research and Treatment|April 26, 2020
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortiumJill R Dietz, Meena S Moran, Steven J Isakoff, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 9, 2008
NCCN Task Force Report: breast cancer in the older womanRobert W Carlson, Susan Moench, Arti Hurria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2003
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741Marc L Citron, Donald A Berry, Constance Cirrincione, et al.
Ebiomedicine|November 4, 2022
Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancerAndrew A Davis, Lorenzo Gerratana, Katherine Clifton, et al.
Breast (Edinburgh, Scotland)|March 8, 2011
Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global InitiativeJoe B Harford, Isabel V Otero, Benjamin O Anderson, et al.
Pageof 20

Showing results (151-160 of 195) with videos related to

Sort By:
Pageof 20
The Journal of Clinical Investigation|March 26, 2024
Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancersYueming Zhu, Anupam Banerjee, Ping Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast CancerCristina Saura, Judit Matito, Mafalda Oliveira, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 4, 2006
HER2 testing in breast cancer: NCCN Task Force report and recommendationsRobert W Carlson, Susan J Moench, M Elizabeth H Hammond, et al.
JCO Oncology Practice|August 10, 2021
Evaluation of the Novel 4R Oncology Care Planning Model in Breast Cancer: Impact on Patient Self-Management and Care Delivery in Safety-Net and Non-Safety-Net CentersJulia R Trosman, Christine B Weldon, Bruce D Rapkin, et al.
Nature Communications|April 14, 2025
MGAT1-Guided complex N-Glycans on CD73 regulate immune evasion in triple-negative breast cancerJunlong Jack Chi, Ping Xie, Mary Hongying Cheng, et al.
Breast Cancer Research and Treatment|April 26, 2020
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortiumJill R Dietz, Meena S Moran, Steven J Isakoff, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 9, 2008
NCCN Task Force Report: breast cancer in the older womanRobert W Carlson, Susan Moench, Arti Hurria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2003
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741Marc L Citron, Donald A Berry, Constance Cirrincione, et al.
Ebiomedicine|November 4, 2022
Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancerAndrew A Davis, Lorenzo Gerratana, Katherine Clifton, et al.
Breast (Edinburgh, Scotland)|March 8, 2011
Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global InitiativeJoe B Harford, Isabel V Otero, Benjamin O Anderson, et al.
Pageof 20